- Home
- BRSP vs CDNA Comparison
BRSP vs CDNA Comparison
Compare BRSP & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRSP
- CDNA
- Stock Information
- Founded
- BRSP 2017
- CDNA 1998
- Country
- BRSP United States
- CDNA United States
- Employees
- BRSP N/A
- CDNA N/A
- Industry
- BRSP Real Estate Investment Trusts
- CDNA Medical Specialities
- Sector
- BRSP Real Estate
- CDNA Health Care
- Exchange
- BRSP Nasdaq
- CDNA Nasdaq
- Market Cap
- BRSP 764.4M
- CDNA 712.2M
- IPO Year
- BRSP 2018
- CDNA 2014
- Fundamental
- Price
- BRSP $5.71
- CDNA $14.30
- Analyst Decision
- BRSP Buy
- CDNA Buy
- Analyst Count
- BRSP 4
- CDNA 8
- Target Price
- BRSP $6.38
- CDNA $26.86
- AVG Volume (30 Days)
- BRSP 568.4K
- CDNA 1.5M
- Earning Date
- BRSP 10-28-2025
- CDNA 11-03-2025
- Dividend Yield
- BRSP 11.21%
- CDNA N/A
- EPS Growth
- BRSP N/A
- CDNA N/A
- EPS
- BRSP N/A
- CDNA 1.00
- Revenue
- BRSP $335,107,000.00
- CDNA $340,826,000.00
- Revenue This Year
- BRSP N/A
- CDNA $13.02
- Revenue Next Year
- BRSP $6.22
- CDNA $12.85
- P/E Ratio
- BRSP N/A
- CDNA $14.21
- Revenue Growth
- BRSP N/A
- CDNA 14.72
- 52 Week Low
- BRSP $4.16
- CDNA $10.96
- 52 Week High
- BRSP $6.45
- CDNA $32.97
- Technical
- Relative Strength Index (RSI)
- BRSP 50.66
- CDNA 59.40
- Support Level
- BRSP $5.87
- CDNA $13.23
- Resistance Level
- BRSP $5.99
- CDNA $13.80
- Average True Range (ATR)
- BRSP 0.11
- CDNA 0.69
- MACD
- BRSP -0.04
- CDNA 0.19
- Stochastic Oscillator
- BRSP 13.24
- CDNA 81.09
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.